Denali Therapeutics Inc. Annual Operating Margin in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Denali Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2018 to 2023.
  • Denali Therapeutics Inc. Operating Margin for the quarter ending March 31, 2024 was -65.5 %, a 83.2% increase year-over-year.
  • Denali Therapeutics Inc. annual Operating Margin for 2023 was -59.5 %, a 81.1% increase from 2022.
  • Denali Therapeutics Inc. annual Operating Margin for 2022 was -314 %, a 48.3% increase from 2021.
  • Denali Therapeutics Inc. annual Operating Margin for 2021 was -608 %, a 3353% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -59.5 +255 +81.1% Jan 1, 2023 Dec 31, 2023
2022 -314 +294 +48.3% Jan 1, 2022 Dec 31, 2022
2021 -608 -626 -3353% Jan 1, 2021 Dec 31, 2021
2020 18.7 +818 Jan 1, 2020 Dec 31, 2020
2019 -799 -763 -2126% Jan 1, 2019 Dec 31, 2019
2018 -35.9 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.